Vascular Imaging Market By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, Nuclear Imaging, X-ray, Others), By Procedure (Coronary Angiography, Peripheral Angiography, Cerebral Angiography, Pulmonary Angiography, Vena Cava Angiography, Others), By Application (Atherosclerosis, Aneurysms, Deep Vein Thrombosis (DVT), Pulmonary Embolism, Stroke, Carotid Artery Disease, Congenital Vascular Disorders, Vascular Tumors, Varicose Veins, Peripheral Arterial Disease (PAD), By End-User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers (ASCs), Academic & Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

---

Industry Outlook

The Vascular Imaging Market accounted for USD 6.75 Billion in 2024 and USD 7.04 Billion in 2025 is expected to reach USD 10.75 Billion by 2035, growing at a CAGR of around 4.32% between 2025 and 2035. The vascular Imaging Market shows sustained growth because cardiovascular disease prevalence is rising while practitioners need non-invasive diagnostic procedures and new imaging tools emerge. Different vascular imaging techniques such as CT angiography and both MRI and Doppler ultrasound assist doctors in diagnosing conditions that include atherosclerosis together with aneurysms or deep vein thrombosis. AI collaborations with 3D imaging systems continue to enhance healthcare evaluation precision while improving staff work processes. Hospitals together with diagnostic centers along with research institutions establish themselves as primary market end-users. Market growth gets additional support from worldwide expanding healthcare costs and increasing elderly populations.

Report Scope:

Market Dynamics

The increasing prevalence of cardiovascular diseases is driving the demand for effective vascular imaging solutions.

Vascular imaging's primary driver of market expansion is the rise in cardiovascular illnesses (CVDs). Because heart disorders, such as peripheral artery disease, coronary artery disease, and stroke, are becoming more common because of poor diets, sedentary lifestyles, and rising obesity rates, there is a need for more accurate and early detection. CT, MRI, ultrasound, and X-ray technology are vital diagnostic tools that assist doctors in creating the most effective treatment plans by identifying blockages and presenting blood movement patterns. Medical imaging systems provide essential tools for monitoring disease progression and detecting problems early, which lowers the risk of catastrophic cardiac events. Since cardiovascular illnesses are the leading cause of death worldwide, the healthcare industry places a stronger priority on early identification. Advanced vascular imaging technologies are being adopted by hospitals' diagnostic centers as they require precise, quick assessments.

Healthcare organizations worldwide and different governments operate awareness campaigns to develop better screening methods for cardiovascular diseases. A larger patient population is now participating in planned medical appointments and testing where vascular imaging is essential. The market expansion is driven by two significant factors, including the aging population that carries higher risks of heart and vascular diseases, and their increased numbers. The implementation of AI algorithms combined with machine learning technologies in diagnostic imaging technologies raises both clinical accuracy and workflow efficiency, which strengthens their implementation across the board. Strong and enduring market demand exists for vascular imaging solutions owing to multiple related factors that gain traction in mature regions and developing markets.

Advancements in imaging technologies, such as 3D and contrast-enhanced imaging, are improving diagnostic accuracy and boosting adoption.

The vascular imaging market expands actively because of new imaging technology innovations, including 3D imaging and contrast-enhanced techniques. Through modern imaging technology, physicians obtain precise blood vessel images and enhanced detection capacity for vascular abnormalities, blockages, and aneurysms. Traditional 2D imaging provides a less comprehensive visual representation of vascular structures than 3D imaging because it offers enhanced surgical planning capabilities, together with reduced diagnostic errors. The addition of iodine or gadolinium contrast agents through mixed imaging techniques enhances visibility by allowing physicians to view blood vessels at various flow areas and narrowing points. Better imaging clarity, together with improved diagnostic accuracy, enables medical professionals to make more objective decisions. Hospitals and specialized vascular clinics, together with diagnostic centers, have experienced rising demand for advanced imaging solutions.

Progressive imaging technologies integrate with AI-enabled software applications that execute automatic image analysis functions alongside decreasing radiologist workloads. The merging of these technologies improves both clinical testing speeds and treatment results, and diagnostic speed. These innovative tools prove beneficial due to healthcare providers' need to enhance service quality and decrease healthcare expenses. The deployment of minimally invasive surgery and the requirement for precise vascular navigation during surgery make high-end imaging systems more necessary each day. Healthcare facilities observe rapid growth in their market due to the technological advancements that are encouraging them to migrate from traditional systems toward contemporary vascular imaging assets that bring numerous features.

High cost of advanced vascular imaging equipment limits accessibility in low-income and rural areas.

Advanced vascular imaging equipment maintains a high price level, which limits the market expansion of vascular imaging technology. Healthcare facilities with limited budgets find it challenging to afford the expensive capital costs needed for MRI and CT scanners that offer enhanced vascular imaging functions. The purchase expenses from a vascular imaging system led to continuous costs because medical facilities must pay for maintenance services, training education, and software program updates. Advanced diagnostic technologies are becoming less accessible for smaller hospitals and clinics, as well as rural health centers, due to their expensive nature.

The lack of supporting infrastructure characterizes lower-income and developing areas, which hinders their ability to obtain these high-end imaging systems. The deployment of these technologies remains restricted in such areas because of limited trained personnel, in addition to unstable power supply, production, and insufficient governmental financial backing. Patients from rural areas and economically challenged regions encounter two major obstacles because these areas lack timely diagnostic services and remote availability of imaging services in urban facilities, which delays proper treatment. The cost barrier establishes a major obstacle in providing universal, equitable vascular imaging solutions to every geographic area.

Expanding telemedicine and remote diagnostics are creating new use cases for portable vascular imaging devices.

New opportunities within the vascular imaging market emerge because of expanding telemedicine and remote diagnostics solutions, which focus on developing portable, compact imaging equipment. The development of digital healthcare requires diagnostic tools that should support remote medical consultations and field assessments, especially for areas with limited access. The efficiency of handheld ultrasound devices and mobile Doppler systems enables their use in home-care settings and other mobile clinics and emergencies. The medical devices provide essential bridge capabilities to enhance accessibility in critical vascular condition detection beyond hospital-based practices.

Through the alignment of telehealth systems with vascular imaging technology, healthcare specialists can inspect scans off-site while promptly providing medical guidance. The equipment enables patients to save costs and time while lowering the stress on central healthcare institutions. The expansion of digital health infrastructure investments worldwide results in the anticipated growth of telemedicine-compatible and portable imaging solutions. The expanding market segment will benefit those medical companies that adopt lightweight devices and simple operations combined with artificial intelligence-based vascular imaging technology to establish themselves and expand their market reach.

Rising healthcare investments in emerging economies offer growth potential for imaging equipment manufacturers.

Manufacturers in the vascular imaging market can benefit from the growing healthcare investments made by emerging economies. Multiple nations throughout Asia-Pacific and Latin America, together with African regions, enhance their health budgets to upgrade their hospital facilities while boosting diagnostic capabilities and enhancing patient care services. Several emerging economies experience rising demand for top medical imaging technologies because their healthcare systems need vascular imaging systems to help detect and treat the increasing number of cardiovascular disease cases.

Manufacturers find great advantage in delivering cost-efficient, durable, yet user-friendly imaging devices specifically designed for scarce-resource environments. The diagnostic services industry belongs to local governments as well as private health administrators who want to form business partnerships and acquisition agreements with worldwide imaging solution providers for hospital facility improvements. The rising adoption of vascular imaging systems stems from positive healthcare policy changes and expanding insurance coverage, alongside the demographic shift of average citizens obtaining better healthcare services. Companies that aim to boost their international reach and sales should consider emerging markets because of the excellent conditions that exist there.

Industry Experts Opinion

‘‘Currently, day-to-day image interrogation for diagnosis, interpretation, and creation with the goal of measuring solutions using standard software remains based on individual expertise and is time-consuming, leaving room for error and variation in interpretation.’’

• Prof. Ducasse, France, CHU Bordeaux

Segment Analysis

Based on Modality, the Vascular Imaging Market is segmented into Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, Nuclear Imaging, X-ray, and Others. The CT segment holds the top position in the market today. The medical community strongly favors CT angiography because of its fast-imaging capabilities, together with its noninvasive approach and accurate blood vessel visualization capabilities. Physicians use this method to inspect aneurysms and vascular blockages, and malformations in particular. Its technological advancements, including real-time imaging and 3D rendering, boosted diagnostic accuracy, making it the leader in the market.

Based on Procedure, the Vascular Imaging Market is segmented into Coronary Angiography, Peripheral Angiography, Cerebral Angiography, Pulmonary Angiography, Vena Cava Angiography, and Others. Coronary Angiography maintains the largest market position since coronary artery diseases are becoming more prevalent, combined with an increasing number of global cardiac medical procedures. Heart blood vessels can be examined with great detail through this imaging method, which is crucial for diagnosing heart conditions and designing heart treatments. The expansion of this segment continues because medical centers in advanced to emerging regions increase their demand for this equipment.

Regional Analysis

The North American Vascular Imaging Market is leading due to advanced healthcare structures combined with high innovation in imaging technology adoption, together with substantial medical device company presence, which drives the market dominance in this area. The need for vascular imaging procedures increases because of two main factors: the rising number of aging people along the expanding cases of cardiovascular diseases. The market experiences strong growth because of supportive reimbursement systems and substantial healthcare spending. The United States takes the lead in regional research expenses, while hospitals and diagnostic centres adopt new technology at early stages.

The Asia Pacific Vascular Imaging Market is the fastest-growing, owing to mounting cases of heart disease, improving disease diagnosis practices, and increased spending on healthcare facilities. Security laboratories in China and India together with Japan keep developing their diagnostic equipment systems to serve growing national populations alongside aging societies. Public healthcare programs, alongside increasing healthcare spending, help patients acquire state-of-the-art medical imaging devices. Local manufacturers extend market growth through their production of budget-friendly imaging devices that meet the specific requirements of the region.

Competitive Landscape

The vascular imaging market demonstrates an intense competitive environment with multiple important international companies that dedicate continuous research investments to improving imaging systems with broad-scale product expansions. Advanced vascular imaging solutions from dominant market players include GE HealthCare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems, which supply high-resolution ultrasound systems, CT/MRI scanners, and hybrid imaging systems to medical organizations. The companies maintain their market position through strategic acquisitions along with innovative technology strategies that involve AI integration and focus on both diagnostic advances and business partnerships. Emerging technology providers, along with local manufacturers, are becoming more successful through their delivery of budget-friendly portable imaging equipment to developing market regions.

 Recent Developments:

• In March 2025, Evident Vascular closed its Series B financing round. New investors included Shangbay Capital and two unnamed multinational strategics, alongside founding investor Vensana Capital. The funds were used to advance the company’s intravascular ultrasound (IVUS) technology. The goal was to support FDA 510(k) clearance and prepare for a U.S. market launch

Report Coverage:

By Modality

• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT)
• Ultrasound
• Nuclear Imaging
• X-ray
• Others

By Procedure

• Coronary Angiography
• Peripheral Angiography
• Cerebral Angiography
• Pulmonary Angiography
• Vena Cava Angiography
• Others

By Application

• Atherosclerosis
• Aneurysms
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism
• Stroke
• Carotid Artery Disease
• Congenital Vascular Disorders
• Vascular Tumors
• Varicose Veins
• Peripheral Arterial Disease (PAD)

By End-User

• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers (ASCs)
• Academic & Research Institutes

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• GE HealthCare
• Siemens Healthineers
• Koninklijke Philips N.V.
• Canon Medical Systems Corporation
• Fujifilm Holdings Corporation
• Shimadzu Corporation
• Hologic, Inc.
• Samsung Medison Co., Ltd.
• Hitachi, Ltd.
• Carestream Health
• Agfa-Gevaert Group
• Esaote SpA
• Ziehm Imaging GmbH
• Mindray Medical International Limited
• Analogic Corporation

Frequently Asked Questions (FAQs)